States Aren ' t Waiting for DC to Regulate Insulin Prices, They ' re Doing Themselves

Back in March 2018, I co-authored (along with Scott King, the former editor ofDiabetes Health magazine) an article (catch the article athttps://www.diabeteshealth.com/good-bad-diabetes-advocacy-world/ for reference) about some patient advocacy wins and challenges ahead. One of the challenges ahead was about runaway insulin prices.We started to see action on runaway insulin prices in state capitals happen a few years ago.Nevada got an early start in 2017, introducing a transparency bill that requires drugmakers who made insulin specifically to report pricing, costs, and rebates. It was signed into law by the state ' s Republican governor. The go-to industry response was to sue Nevada in Court. But when two lawsuits from PhRMA and BIO were both thrown out of court because the industry failed to demonstrate they would suffer financial harm from complying with the law, it went into effect. Nevada ' s price-transparency law irritated the hell out of the pharmaceutical industry, but they lost in Court (see https://thenevadaindependent.com/article/big-pharma-abandons-lawsuit-over-nevadas-insulin-pricing-transparency-law-after-state-approves-trade-secret-protection-regulations for detail) and as non-compliance fees started growing, they were forced to comply, albeit reluctantly. But the Nevada law did not do much to impact runaway prices, but it did enable Nevada lawmakers to better understand the problem.Colorado acted in May 2019, implementing a cap on co-payments of...
Source: Scott's Web Log - Category: Endocrinology Tags: 2020 insulin insulin prices legislation state laws Source Type: blogs